Shukra Pharmaceuticals Ltd — Board Meeting, 04-02-2026: Board Meeting
04-02-2026 | 04:07 pm
04-02-2026 | 04:07 pm
Board approved the financial results for the quarter & nine-month ended Dec 31, reporting Net Profit of ₹20.36 Cr for the quarter and ₹23.77 Cr for nine months. Mr. Dakshesh Shah was also re-appointed MD for 5 years.
No comments yet. Be the first to comment!
